-
Replimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line
2026-08-08 10:22:58
-
NET, ZS, PANW End Second Week Higher — Citrini Research Sees Cybersecurity Stocks Pulling Further Ahead Of Software
2026-08-08 10:22:57
-
Ink attack on AISA President: Neha Bora demands security answers
2026-08-08 10:22:56
-
SS Rajamouli’s Daughter-in-Law Pooja Prasad’s Film Family Roots: All You Need To Know
2026-08-08 10:22:54
-
Priyank Kharge questions PM Modi’s absence, asks who is running India
2026-08-08 09:22:55
-
HP CM Sukhu pushes for research in medical colleges for better healthcare
2026-08-08 09:22:54
-
ASEAN Day: ASEAN flag illuminates Delhi’s Qutub Minar for first time
2026-08-08 09:22:52
-
Jharkhand Govt to Address Student Concerns, CM’s Office Reviewing
2026-08-08 08:23:03
-
MP Stock Heads For Best Week In 10 Months: CEO Says Demand Continues To ‘Outpace Our Production Growth’
2026-08-08 08:23:02
-
Abelardo De La Espriella sworn in as Colombia’s new President
2026-08-08 08:23:01